Valuation: AVINGER

Market Cap 27.07L 24.05L 22.45L 20.46L 38.59L 26Cr 38.95L 2.72Cr 1.05Cr 13Cr 1.02Cr 99.43L 43Cr P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 1.28Cr 1.14Cr 1.06Cr 96.95L 1.83Cr 123.31Cr 1.85Cr 13Cr 4.99Cr 63Cr 4.82Cr 4.71Cr 202.31Cr EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 05/08/2024
Change 5-day change 1-year change 3-year change Capi.($)
Average
Weighted average by Cap.

Financials

2022 2023
Net sales 82.73L 73.51L 68.61L 62.53L 1.18Cr 80Cr 1.19Cr 8.3Cr 3.22Cr 41Cr 3.11Cr 3.04Cr 130.48Cr 76.52L 67.99L 63.46L 57.84L 1.09Cr 74Cr 1.1Cr 7.68Cr 2.98Cr 38Cr 2.87Cr 2.81Cr 120.69Cr
Net income -1.76Cr -1.57Cr -1.46Cr -1.33Cr -2.51Cr -169.41Cr -2.54Cr -18Cr -6.85Cr -87Cr -6.62Cr -6.47Cr -277.95Cr -1.83Cr -1.63Cr -1.52Cr -1.38Cr -2.61Cr -176.12Cr -2.64Cr -18Cr -7.12Cr -90Cr -6.88Cr -6.73Cr -288.95Cr
Net Debt 17.56L 15.6L 14.56L 13.27L 25.03L 17Cr 25.27L 1.76Cr 68.29L 8.63Cr 65.93L 64.5L 28Cr 1.01Cr 89.92L 83.92L 76.49L 1.44Cr 97Cr 1.46Cr 10Cr 3.94Cr 50Cr 3.8Cr 3.72Cr 159.61Cr
Logo AVINGER
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
-